Stocktoria
BECTON DICKINSON & CO BDX
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1963-09-25
BECTON DICKINSON & CO financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $21.8B | $20.2B | $19.4B | $18.9B | $19.1B |
| R&D expense | $1.3B | $1.2B | $1.2B | $1.3B | $1.3B |
| SG&A expense | $5.3B | $4.9B | $4.7B | $4.7B | $4.7B |
| Operating income | $2.6B | $2.4B | $2.1B | $2.3B | $2.2B |
| Interest expense | $613.0M | $528.0M | $452.0M | $398.0M | $469.0M |
| Income tax | $203.0M | $300.0M | $132.0M | $148.0M | $88.0M |
| Net income | $1.7B | $1.7B | $1.5B | $1.8B | $2.1B |
| EPS (diluted) | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 |
| Operating cash flow | $3.4B | $3.8B | $3.0B | $2.5B | $4.6B |
| Free cash flow | $2.7B | $3.1B | $2.1B | $1.5B | $3.5B |
| Cash & equivalents | $567.0M | $1.7B | $1.4B | $1.0B | $2.3B |
| Inventory | $3.1B | $3.8B | $3.3B | $3.2B | $2.7B |
| Total assets | $55.3B | $57.3B | $52.8B | $52.9B | $53.9B |
| Shareholders' equity | $25.4B | $25.9B | $25.8B | $25.3B | $23.7B |
Source: SEC EDGAR filings · CIK 0000010795 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.